HK1111441A1 - Method for measuring resistance or sensitivity to docetaxel - Google Patents

Method for measuring resistance or sensitivity to docetaxel

Info

Publication number
HK1111441A1
HK1111441A1 HK08101872.3A HK08101872A HK1111441A1 HK 1111441 A1 HK1111441 A1 HK 1111441A1 HK 08101872 A HK08101872 A HK 08101872A HK 1111441 A1 HK1111441 A1 HK 1111441A1
Authority
HK
Hong Kong
Prior art keywords
docetaxel
sensitivity
measuring resistance
measuring
resistance
Prior art date
Application number
HK08101872.3A
Other languages
English (en)
Inventor
Dorre Grueneberg
Xi Huang
Sridaran Natesan
Paul August
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of HK1111441A1 publication Critical patent/HK1111441A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK08101872.3A 2004-12-08 2008-02-21 Method for measuring resistance or sensitivity to docetaxel HK1111441A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63429804P 2004-12-08 2004-12-08
PCT/US2005/043578 WO2006062811A2 (fr) 2004-12-08 2005-12-01 Procede de mesure de la resistance ou de la sensibilite au docetaxel

Publications (1)

Publication Number Publication Date
HK1111441A1 true HK1111441A1 (en) 2008-08-08

Family

ID=36512512

Family Applications (2)

Application Number Title Priority Date Filing Date
HK08101872.3A HK1111441A1 (en) 2004-12-08 2008-02-21 Method for measuring resistance or sensitivity to docetaxel
HK11108630.6A HK1153786A1 (en) 2004-12-08 2011-08-16 Method for measuring resistance or sensitivity to docetaxel

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK11108630.6A HK1153786A1 (en) 2004-12-08 2011-08-16 Method for measuring resistance or sensitivity to docetaxel

Country Status (16)

Country Link
US (2) US20090226894A1 (fr)
EP (10) EP2395106A1 (fr)
JP (5) JP5139811B2 (fr)
KR (10) KR101347106B1 (fr)
CN (10) CN102618641B (fr)
AR (1) AR051523A1 (fr)
AU (1) AU2005314335C1 (fr)
BR (1) BRPI0518884A2 (fr)
CA (1) CA2589918A1 (fr)
HK (2) HK1111441A1 (fr)
IL (9) IL183718A (fr)
MX (1) MX2007006867A (fr)
RU (2) RU2403574C2 (fr)
SG (2) SG156625A1 (fr)
TW (10) TW201241178A (fr)
WO (1) WO2006062811A2 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0606096D0 (en) 2006-03-27 2006-05-03 Cbmm Sa Screening method
EP2468886A1 (fr) * 2006-12-13 2012-06-27 Oncotherapy Science, Inc. TTK utilisé en tant que marqueur tumoral et cible thérapeutique pour cancer du poumon
KR101791981B1 (ko) * 2007-03-14 2017-11-01 비온실 에스.알.엘. 화학요법 약물-내성 상피성 종양을 치료하기 위한 ｓｉＲＮＡ-매개 유전자 침묵화
GB2460769C (en) * 2007-11-30 2011-09-07 Applied Genomics Inc TLE3 as a marker for chemotherapy
EP2177630A1 (fr) 2008-10-02 2010-04-21 Institut Gustave Roussy Procédés de prédiction ou de suivi du fait qu'un patient atteint d'un cancer répond à une traitement par une molécule de la famille des taxoïdes
TW201102081A (en) 2009-05-11 2011-01-16 Oncotherapy Science Inc TTK peptides and vaccines including the same
EP2493466B1 (fr) 2009-10-29 2021-03-10 Sanofi Mature IP Nouvelle utilisation antitumorale du cabazitaxel
US20130130928A1 (en) 2010-04-08 2013-05-23 Institut Gustave Roussy Methods for predicting or monitoring whether a patient affected by a cancer is responsive to a treatment with a molecule of the taxoid family
JP2012005479A (ja) * 2010-05-26 2012-01-12 Japanese Foundation For Cancer Research 抗癌剤のスクリーニング方法
WO2012098207A1 (fr) * 2011-01-21 2012-07-26 Basilea Pharmaceutica Ag Utilisation du bubr1 comme biomarqueur de réponse médicamenteuse aux furazanobenzimidazoles
SG11201402143YA (en) * 2011-11-21 2014-06-27 Taivex Therapeutics Corp Biomarkers for cancers responsive to modulators of hec1 activity
WO2013078537A1 (fr) * 2011-11-28 2013-06-06 National Research Council Of Canada Marqueurs de réponse au paclitaxel pour le cancer
CN102621325B (zh) * 2012-04-06 2014-11-12 上海蓝怡科技有限公司 用于检测血液中多西他赛浓度的试剂盒
CN105803053B (zh) * 2014-12-31 2021-03-16 上海吉凯基因科技有限公司 人rbm17基因的用途及其相关药物
CN105925611A (zh) * 2016-04-23 2016-09-07 同济大学苏州研究院 靶向hsp70基因rna干扰重组慢病毒载体及其构建方法
CN107447028A (zh) * 2017-09-13 2017-12-08 赵小刚 检测rb1基因i680t位点突变的试剂盒
CN113855675A (zh) * 2018-05-22 2021-12-31 郑州大学第一附属医院 基于胆囊癌标志物的试剂盒及药物
CN111944905B (zh) * 2020-08-20 2023-06-02 武汉凯德维斯医学检验实验室有限公司 人类基因组合及其在制备评估宫颈癌新辅助化疗药物敏感性试剂盒中的应用
KR102605155B1 (ko) 2022-03-04 2023-11-23 우순 다기능 표적 이송장치
KR102596893B1 (ko) 2022-03-04 2023-11-01 우순 표적지 이송장치

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7807532A (nl) 1978-07-13 1980-01-15 Akzo Nv Metaal-immunotest.
NL8000173A (nl) 1980-01-11 1981-08-03 Akzo Nv Toepassing van in water dispergeerbare, hydrofobe kleurstoffen als label in immunochemische testen.
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4703017C1 (en) 1984-02-14 2001-12-04 Becton Dickinson Co Solid phase assay with visual readout
JPS61231031A (ja) * 1985-04-08 1986-10-15 Agency Of Ind Science & Technol 二硫化炭素重合体の製造方法
US5225539A (en) * 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
DE3882058T2 (de) 1987-02-27 1994-01-13 Eastman Kodak Co Immunoreaktives Reagens, Verfahren zu seiner Herstellung und seine Verwendung zur Bestimmung einer immunoreaktiven Spezies.
EP0280559B1 (fr) 1987-02-27 1993-10-20 EASTMAN KODAK COMPANY (a New Jersey corporation) Essai immunologique d'agglutination et trousse de réactifs pour la détermination d'une espèce immunollogique polyvalente utilisant une solution saline de nettoyage tamponnée
US4857453A (en) 1987-04-07 1989-08-15 Syntex (U.S.A.) Inc. Immunoassay device
ATE195022T1 (de) 1987-04-27 2000-08-15 Unilever Nv Spezifische bindungstestverfahren
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5859205A (en) 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
WO1997005157A1 (fr) * 1995-08-01 1997-02-13 Sloan-Kettering Institute For Cancer Research Gene codant l'homologue humain de mad2
US6410312B1 (en) * 1997-12-19 2002-06-25 Chiron Corporation huBUB3 gene involved in human cancers
AU7828698A (en) * 1997-06-11 1998-12-30 Chiron Corporation Detection of loss of the wild-type (hu)bub1 gene
CA2311414A1 (fr) * 1997-11-27 1999-06-10 Chugai Research Institute For Molecular Medicine, Inc. Technique de diagnostique, reactif pour diagnostique et preparation therapeutique pour les maladies provoquees par des modifications survenues dans le gene lkb1
WO1999042828A2 (fr) * 1998-02-18 1999-08-26 Theryte Limited Traitement du cancer
US6350452B1 (en) * 1998-09-24 2002-02-26 Promega Corporation Apoptosis marker antibodies and methods of use
WO2000035473A2 (fr) * 1998-12-18 2000-06-22 Scios Inc. Methodes de detection et d'utilisation de genes exprimes de façon differentielle dans des maladies
WO2001061050A2 (fr) * 2000-02-17 2001-08-23 Millennium Pharmaceuticals, Inc. Procedes et composition destines a l'identification, l'evaluation, la prevention et la therapie de cancers chez l'homme
US20020051978A1 (en) * 2000-02-17 2002-05-02 Roth Frederick P. Methods and compositions for the identification, assessment, prevention and therapy of human cancers
WO2002068444A1 (fr) * 2001-02-21 2002-09-06 Chiron Corporation Utilisation de la ttk à des fins de diagnostic et comme cible thérapeutique du cancer
US6783597B2 (en) * 2001-03-13 2004-08-31 3M Innovative Properties Company Filament recoating apparatus and method
US7229774B2 (en) * 2001-08-02 2007-06-12 Regents Of The University Of Michigan Expression profile of prostate cancer
DE10139283A1 (de) * 2001-08-09 2003-03-13 Epigenomics Ag Verfahren und Nukleinsäuren zur Analyse von Colon-Krebs
US20030235581A1 (en) * 2002-06-20 2003-12-25 George Pieczenik Ligands for Reproductive Science
JP2006517387A (ja) * 2002-09-11 2006-07-27 ジェネンテック・インコーポレーテッド 腫瘍の診断と治療のための組成物と方法
US20040214203A1 (en) * 2002-12-12 2004-10-28 Oncotech, Inc. Genes related to sensitivity and resistance to chemotherapeutic drug treatment
DE10260264A1 (de) * 2002-12-20 2004-07-01 GSF-Forschungszentrum für Umwelt und Gesundheit GmbH Verfahren und Zelllinie zur Identifizierung proliferationshemmender, anti-inflammatorischer oder proliferationsfördender Wirkstoffe
EP1661991A4 (fr) * 2003-08-24 2007-10-10 Univ Nihon Gene associe au cancer hepatocellulaire
US20050136177A1 (en) * 2003-08-25 2005-06-23 Anthony Hesse Method for coloring landscaping materials using foamable dry colorant
ES2550614T3 (es) * 2004-04-09 2015-11-11 Genomic Health, Inc. Marcadores de expresión génica para predecir la respuesta a la quimioterapia
JP2006014722A (ja) * 2004-06-02 2006-01-19 Keio Gijuku 遺伝子マーカー及びその利用
GB0426393D0 (en) * 2004-12-01 2005-01-05 Cancer Rec Tech Ltd Materials and methods relating to modulators of spindle checkpoint kinases
US7957910B2 (en) * 2005-01-31 2011-06-07 Sysmex Corporation Method for predicting effectiveness of chemotherapy
EP2177630A1 (fr) * 2008-10-02 2010-04-21 Institut Gustave Roussy Procédés de prédiction ou de suivi du fait qu'un patient atteint d'un cancer répond à une traitement par une molécule de la famille des taxoïdes

Also Published As

Publication number Publication date
CN102634574A (zh) 2012-08-15
JP5531001B2 (ja) 2014-06-25
WO2006062811A2 (fr) 2006-06-15
CN101974619B (zh) 2012-11-21
IL183718A0 (en) 2007-09-20
IL225469A0 (en) 2013-06-27
CN101974619A (zh) 2011-02-16
TW201241178A (en) 2012-10-16
KR20130099246A (ko) 2013-09-05
EP2395105A1 (fr) 2011-12-14
KR20130105761A (ko) 2013-09-25
JP2008522615A (ja) 2008-07-03
SG156625A1 (en) 2009-11-26
EP2395104A1 (fr) 2011-12-14
KR101357039B1 (ko) 2014-02-03
TW201237176A (en) 2012-09-16
WO2006062811A3 (fr) 2006-09-14
KR101347106B1 (ko) 2014-01-02
JP2012115267A (ja) 2012-06-21
EP2395107A1 (fr) 2011-12-14
CN102747140A (zh) 2012-10-24
IL221772A0 (en) 2012-10-31
CA2589918A1 (fr) 2006-06-15
JP2012100666A (ja) 2012-05-31
KR101347107B1 (ko) 2014-01-02
CN102618642B (zh) 2014-12-31
IL221772A (en) 2014-06-30
IL225468A0 (en) 2013-06-27
IL210298A (en) 2012-12-31
EP2395106A1 (fr) 2011-12-14
CN101072883A (zh) 2007-11-14
JP5139811B2 (ja) 2013-02-06
TW201237179A (en) 2012-09-16
CN101072883B (zh) 2012-05-23
AU2005314335B2 (en) 2012-02-02
TW201237177A (en) 2012-09-16
TW201241177A (en) 2012-10-16
IL205702A0 (en) 2011-07-31
KR101357032B1 (ko) 2014-02-03
AU2005314335C1 (en) 2012-08-16
CN102747142A (zh) 2012-10-24
JP5531002B2 (ja) 2014-06-25
TW201237175A (en) 2012-09-16
IL210298A0 (en) 2011-03-31
IL210299A0 (en) 2011-03-31
TW201237178A (en) 2012-09-16
MX2007006867A (es) 2007-08-06
IL183718A (en) 2013-04-30
KR20130113527A (ko) 2013-10-15
KR101357035B1 (ko) 2014-02-03
KR20130105760A (ko) 2013-09-25
KR20130105759A (ko) 2013-09-25
EP1831398A2 (fr) 2007-09-12
EP1831398B1 (fr) 2014-10-29
EP2395103A1 (fr) 2011-12-14
EP2395110A1 (fr) 2011-12-14
EP2395102A1 (fr) 2011-12-14
EP2395108A1 (fr) 2011-12-14
RU2403574C2 (ru) 2010-11-10
RU2007125722A (ru) 2009-01-20
CN102618641A (zh) 2012-08-01
TW200636076A (en) 2006-10-16
KR101323574B1 (ko) 2013-10-30
KR20070085986A (ko) 2007-08-27
BRPI0518884A2 (pt) 2008-12-30
IL205636A (en) 2012-08-30
JP5531000B2 (ja) 2014-06-25
JP2012100665A (ja) 2012-05-31
CN102618642A (zh) 2012-08-01
US20090226894A1 (en) 2009-09-10
US20130252837A1 (en) 2013-09-26
CN102605066A (zh) 2012-07-25
KR20130105762A (ko) 2013-09-25
CN102634574B (zh) 2014-11-12
EP2395109A1 (fr) 2011-12-14
HK1153786A1 (en) 2012-04-05
KR101357038B1 (ko) 2014-02-03
KR101357040B1 (ko) 2014-02-03
JP5530999B2 (ja) 2014-06-25
KR20130004381A (ko) 2013-01-09
CN102747141A (zh) 2012-10-24
KR20130113526A (ko) 2013-10-15
IL210299A (en) 2012-12-31
AU2005314335A1 (en) 2006-06-15
KR101357033B1 (ko) 2014-02-03
IL205635A (en) 2013-02-28
KR20130105758A (ko) 2013-09-25
KR101357037B1 (ko) 2014-02-03
TW201241176A (en) 2012-10-16
RU2010122759A (ru) 2011-12-10
TW201237174A (en) 2012-09-16
JP2012120532A (ja) 2012-06-28
CN102618641B (zh) 2014-08-13
CN102605067A (zh) 2012-07-25
AR051523A1 (es) 2007-01-17
SG194337A1 (en) 2013-11-29

Similar Documents

Publication Publication Date Title
IL225469A0 (en) A method for measuring resistance or sensitivity to docetaxel
EP1878996A4 (fr) Compteur de distance/vitesse et procede de mesure de distance/vitesse
EP2131205A4 (fr) Détecteur magnétique et son procédé de mesure de sensibilité
EP2108233A4 (fr) Procédé de détermination d'emplacement basé sur la comparaison de signal
EP2215450A4 (fr) Méthodes et compositions pour détection d'analytes
EP1746385A4 (fr) Procede de mesure d'un petit deplacement et instrument
GB2425843B (en) Method and device for measuring capacitances
EP1779487A4 (fr) Circuit isolé de mesure de la valeur ohmique d'un capteur
EP2060893A4 (fr) Procédé de mesure de valeur de distribution et système de mesure utilisant un capteur de valeur de distribution pour celui-ci
HK1099813A1 (en) Distance measuring device and distance measuring method
GB0522015D0 (en) Improvements in or relating to sensing apparatus
EP1891414A4 (fr) Capteur, capteur multivoies, appareil de detection, et procede de detection
EP2093536A4 (fr) Dispositif de mesure et procédé de mesure
HK1107399A1 (en) Adjustable measuring scoop
EP2157405A4 (fr) Dispositif et procédé de mesure de quantité physique
GB2442852B (en) Stress measurement method
EP1760455A4 (fr) Dispositif de mesure
EP1739407A4 (fr) Capteur, équipement de mesure et méthode de mesure
PL1715316T3 (pl) Układ czujników pomiarowych
EP2059116A4 (fr) Procédé et dispositif pour mesurer une pièce de bois d'oeuvre
EP1872143A4 (fr) Procede et dispositif de mesure de la resistance
PL1934559T3 (pl) Czujnik i sposób pomiaru położenia i prędkości
EP2003447A4 (fr) Procede de mesure d'une proteine
FI20055231A0 (fi) Menetelmä ja mittalaite mitata vesipitoisuutta
GB2436147B (en) Potentiometric measuring chain

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20161201